Related references
Note: Only part of the references are listed.Can information on functional and cognitive status improve short-term mortality risk prediction among community-dwelling older people? A cohort study using a UK primary care database
Janet Sultana et al.
CLINICAL EPIDEMIOLOGY (2018)
Long-term use of proton pump inhibitors and prevalence of disease-and drug-related reasons for gastroprotection-a cross-sectional population-based study
Susanna M. Wallerstedt et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients
Sai-Wai Ho et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2017)
Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study
Jaymin B. Morjaria et al.
LUNG (2017)
Biological substantiation of antipsychotic-associated pneumonia: Systematic literature review and computational analyses
Janet Sultana et al.
PLOS ONE (2017)
Benzodiazepine and Z-drug use and risk of pneumonia in patients with chronic kidney disease: A population-based nested casecontrol study
Meng-Ting Wang et al.
PLOS ONE (2017)
Risk Factors for Community-Acquired Pneumonia in Adults: A Systematic Review of Observational Studies
Jordi Almirall et al.
RESPIRATION (2017)
Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial
Courtney Crim et al.
RESPIRATORY MEDICINE (2017)
Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study
Javier Gorricho et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Association of Inhaled Corticosteroids with Incident Pneumonia and Mortality in COPD Patients; Systematic Review and Meta-Analysis
Emir Festic et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2016)
The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based Study
Janet Sultana et al.
CNS DRUGS (2016)
Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD
Jadwiga A. Wedzicha et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Metformin and other glucose-lowering drug initiation and rates of community-based antibiotic use and hospital-treated infections in patients with type 2 diabetes: a Danish nationwide population-based cohort study
Anil Mor et al.
BMJ OPEN (2016)
ATP4a is required for development and function of the Xenopus mucociliary epidermis - a potential model to study proton pump inhibitor-associated pneumonia
Peter Walentek et al.
DEVELOPMENTAL BIOLOGY (2015)
Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes
J. -L. Faillie et al.
DIABETES OBESITY & METABOLISM (2015)
Managing the safety of inhaled corticosteroids in COPD and the risk of pneumonia
Adamantia Liapikou et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Anticholinergic Medications and Risk of Community-Acquired Pneumonia in Elderly Adults: A Population-Based Case-Control Study
Kathleen J. Paul et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2015)
Comparative safety of atypical antipsychotics and the risk of pneumonia in the elderly
Sandhya Mehta et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2015)
Antipsychotic drug exposure and risk of pneumonia: a systematic review and meta-analysis of observational studies
Michela Nose et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2015)
Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia: A Population-Based Cohort Study
Rogier Wvan Der Zanden et al.
PLOS ONE (2015)
Antipsychotic use in elderly patients and the risk of pneumonia
Giovanni Gambassi et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis
Allison A. Lambert et al.
PLOS ONE (2015)
Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis
Kristian B. Filion et al.
GUT (2014)
Prehospital Use of Inhaled Corticosteroids and Point Prevalence of Pneumonia at the Time of Hospital Admission: Secondary Analysis of a Multicenter Cohort Study
Emir Festic et al.
MAYO CLINIC PROCEEDINGS (2014)
Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
Helgo Magnussen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Risk of Pneumonia with Inhaled Corticosteroid versus Long-Acting Bronchodilator Regimens in Chronic Obstructive Pulmonary Disease: A New-User Cohort Study
Rachael L. DiSantostefano et al.
PLOS ONE (2014)
Inhaled corticosteroids and pneumonia in chronic obstructive pulmonary disease
Lydia Finney et al.
LANCET RESPIRATORY MEDICINE (2014)
Risk of Pneumonia in Elderly Nursing Home Residents Using Typical Versus Atypical Antipsychotics
Rajender R. Aparasu et al.
ANNALS OF PHARMACOTHERAPY (2013)
Inhaled Corticosteroids and Risk of Recurrent Pneumonia: A Population-Based, Nested Case-Control Study
Dean T. Eurich et al.
CLINICAL INFECTIOUS DISEASES (2013)
Second-Generation Antipsychotic Medications and Risk of Pneumonia in Schizophrenia
Chian-Jue Kuo et al.
SCHIZOPHRENIA BULLETIN (2013)
Risk factors for community-acquired pneumonia in adults in Europe: a literature review
Antoni Torres et al.
THORAX (2013)
Inhaled corticosteroids in COPD and the risk of serious pneumonia
Samy Suissa et al.
THORAX (2013)
Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS)
Christer Janson et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Viral and Bacterial Interactions in the Upper Respiratory Tract
Astrid A. T. M. Bosch et al.
PLOS PATHOGENS (2013)
Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study
Claus F. Vogelmeier et al.
LANCET RESPIRATORY MEDICINE (2013)
Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies
Samuel S. Engel et al.
DIABETES THERAPY (2013)
Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia
C. P. C. de Jager et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: systematic review and meta-analysis
K. Goossen et al.
DIABETES OBESITY & METABOLISM (2012)
Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial
Kentaro Sugano et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Comparative Safety of Antipsychotic Medications in Nursing Home Residents
Krista F. Huybrechts et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2012)
The natural history of community-acquired pneumonia in COPD patients: A population database analysis
Hana Muellerova et al.
RESPIRATORY MEDICINE (2012)
Effect of budesonide/formoterol pMDI on COPD exacerbations: A double-blind, randomized study
Amir Sharafkhaneh et al.
RESPIRATORY MEDICINE (2012)
Clinical and economic burden of community-acquired pneumonia among adults in Europe
T. Welte et al.
THORAX (2012)
Observational Study of Inhaled Corticosteroids on Outcomes for COPD Patients with Pneumonia
Dennis Chen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis
Chun-Sick Eom et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2011)
Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population
A. H. W. Bruns et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Use of Dipeptidyl Peptidase-4 Inhibitors and the Reporting of Infections: A Disproportionality Analysis in the World Health Organization VigiBase
Marjolein J. Willemen et al.
DIABETES CARE (2011)
Risk of Hospitalization for Hip Fracture and Pneumonia Associated with Antipsychotic Prescribing in the Elderly A Self-Controlled Case-Series Analysis in an Australian Health Care Claims Database
Nicole Pratt et al.
DRUG SAFETY (2011)
Microbial evaluation of proton-pump inhibitors and the risk of pneumonia
S. C. A. Meijvis et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Long-term use of thiazolidinediones and the associated risk of pneumonia or lower respiratory tract infection: systematic review and meta-analysis
Sonal Singh et al.
THORAX (2011)
Antipsychotic Drug Use and Community-Acquired Pneumonia
Gianluca Trifirò
Current Infectious Disease Reports (2011)
Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia
J. Johnstone et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Association of Community-Acquired Pneumonia With Antipsychotic Drug Use in Elderly Patients A Nested Case-Control Study
Gianluca Trifiro et al.
ANNALS OF INTERNAL MEDICINE (2010)
Risk of pneumonia associated with long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease: a critical review and update
Sonal Singh et al.
CURRENT OPINION IN PULMONARY MEDICINE (2010)
Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia
R. Malo de Molina et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Inhaled drugs as risk factors for community-acquired pneumonia
J. Almirall et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study
Sascha Dublin et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD
Min J. Joo et al.
RESPIRATORY MEDICINE (2010)
Pharmacotherapy and the risk for community-acquired pneumonia
Jen-Tzer Gau et al.
BMC GERIATRICS (2010)
Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes
Antonio Anzueto et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2009)
Treatment patterns and symptom control in patients with GERD: US community-based survey
William D. Chey et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Acid-suppressive Drugs and Community-acquired Pneumonia
Luis Alberto Garcia Rodriguez et al.
EPIDEMIOLOGY (2009)
Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results
C. Crim et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Budesonide and the risk of pneumonia: a meta-analysis of individual patient data
Don D. Sin et al.
LANCET (2009)
Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study
Puja R. Myles et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort
David M. Mannino et al.
RESPIRATORY MEDICINE (2009)
Antipsychotic Drug Use Among Elderly Nursing Home Residents in the United States
Pravin Kamble et al.
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2008)
The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide
Jadwiga A. Wedzicha et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Proton-pump inhibitor use and the risk for community-acquired pneumonia
Monika Sarkar et al.
ANNALS OF INTERNAL MEDICINE (2008)
New evidence of risk factors for community-acquired pneumonia:: a population-based study
J. Almirall et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Inhaled Corticosteroids in Patients With Stable Chronic Obstructive Pulmonary Disease A Systematic Review and Meta-analysis
M. Bradley Drummond et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Antipsychotic drug use and risk of pneumonia in elderly people
Wilma Knol et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)
Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia
Pierre Ernst et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Use of proton pump inhibitors and the risk of community-acquired pneumonia - A population-based case-control study
Sinem Ezgi Gulmez et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
Peter M. A. Calverley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease
Peter Kardos et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Risk of mortality associated with antipsychotic and other neuropsychiatric drugs in pneumonia patients
MJ Barnett et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS):: a randomised placebo-controlled trial
M Decramer et al.
LANCET (2005)
Extrapyramidal symptoms with atypical antipsychotics - Incidence, prevention and management
JM Pierre
DRUG SAFETY (2005)
Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs
RJF Laheij et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
A new mechanism for anti-inflammatory actions of proton pump inhibitors - inhibitory effects on neutrophil-endothelial cell interactions
N Yoshida et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
Risk factors for community-acquired pneumonia diagnosed by general practitioners in the community
BM Farr et al.
RESPIRATORY MEDICINE (2000)
Share Paper
